Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07598214 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Diosmin/Hesperidin Combination on Platinum Compounds-Induced Nephropathy in Cancer Patients

Study acronym: Dios/Hes-PT
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The current study aims to investigate the protective properties of diosmin/hesperidin on cisplatin-induced nephrotoxicity.
Trial Details
NCT Number NCT07598214
Lead Sponsor Beni-Suef University
Conditions
(from sponsor)		 Cancer Patients
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov